CONMED (CNMD) is Upgraded by Ladenburg Thalmann to Buy , according to the research report released to the investors. Earlier the firm had a rating of Neutral on the company shares. The shares recommendation by the Brokerage Firm was released

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone